Venture Capital & Angel Financing

Overview

Our attorneys regularly represent venture capital, corporate and angel investors as well as growing companies in a wide range of financing transactions, including:

Early stage seed rounds
Convertible debt financing
Institutional venture rounds
Syndicated investment special purpose vehicles
Broker and company sold private placements
Secondary sales of portfolio companies
Secondary sales of partnership interest
Investor representation in connection with disposition or IPO of portfolio companies

Clients include venture capital funds, strategic corporate investors, hedge funds and angel investors, start-up companies and other rapid growth enterprises.

We understand the market within which venture capital transactions operate. We have developed a strong practice by delivering the highest caliber of work while being able to respond to our clients’ need to complete transactions in a timely and cost-effective manner.

Our deep experience with private financing transactions and solid understanding of the venture capital industry has guided our development of a disciplined, process driven approach to venture capital and angel financing transactions. Whether representing an investor or company we:

Understand that your objective is our success, so we start every engagement with one question—what do you hope to achieve?
Create a transaction plan, schedule and team to meet your objectives
Ensure that senior legal leadership is heavily involved in your transaction
Utilize a disciplined and methodical document drafting, review and negotiation process
Provide structured due diligence review and disclosure review process

Experience

We have closed thousands of private financing transactions with an aggregate value in excess of $2 billion.

Representative Cases

Over $2 billion in venture financings
Represented $1 billion plus venture firm in over 200 investments
Represented Fortune 100 retailer’s corporate venture capital group in numerous venture investments
Represented Fortune 500 medical device company in numerous venture investments
Represented numerous venture investors throughout U.S. in seed stage, venture and late stage investments
Represented investors in secondary acquisition of portfolio securities
Represented venture investors in over $1 billion in exit transactions